Page 2 - Bdr Pharma News Today

Midostaurin is launched under the brand name MSTARIN and will be available in the strength of 25 mg

Rucaparib is launched under the brand name BDPARIB in two strengths of 200 mg and 300 mg

BDR Pharma gets FDA nod to distribute Remdesivir to Maharashtra BDR Pharmaceutical International had produced Remdesivir vials for export purpose but with FDA’s order it has been permitted to distribute strictly for Maharashtra Government supply or trade in the state only Mumbai: In a bid to address the shortage of Remdesivir vials, the Food and Drugs Administration (FDA) in its order has allowed the BDR Pharmaceutical International to distribute Remdesivir injections under emergency and v...